Identification of proteins interacting with RNAPII FCP1 phosphatase: FCP1 forms a complex with arginine methyltransferase PRMT5 and it is a substrate for PRMT5-mediated methylation

被引:56
|
作者
Amente, S
Napolitanoa, G
Lieciardo, P
Monti, M
Pucci, P
Lania, L
Majello, B
机构
[1] Univ Naples Federico II, Dept Genet Gen & Mol Biol, I-80134 Naples, Italy
[2] Univ Naples Federico II, Dept Organ Chem & Biochem, I-80134 Naples, Italy
关键词
proteomic; FCP1; phosphatase; RNA polymerase II; PRMT5;
D O I
10.1016/j.febslet.2004.12.045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FCP1, a phosphatase specific of the carboxyl-terminal-domain of the large subunit of the RNA polymerase 11 (RNAPII), stimulates transcription elongation and it is required for general transcription and cell viability. To identify novel interacting proteins of FCP1, we used a human cell line expressing an epitope flagged FCP1 and proteins, which formed complexes with FCP1, were identified by mass spectrometry. We identified four proteins: RPB2 subunit of the RNAPII, the nuclear kinase, NDR1, the methyltransferase PRMT5 and the enhancer of rudimentary homologue (ERH) proteins. Intriguingly, both the PRMT5 and ERH proteins are interacting partners of the SPT5 elongation factor. Interactions of RPB2, ERH, NDR1 and PRMT5 with FCP1 were confirmed by co-immuno-precipitation or in vitro pull-down assays. Interaction between PRNIT5 and FCP1 was further confirmed by co-immunoprecipitation of endogenous proteins. We found that FCP1 is a genuine substrate of PRMT5-methylation both in vivo and in vitro, and FCP1-associated PRMT5 can methylate histones H4 in vitro. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:683 / 689
页数:7
相关论文
共 44 条
  • [31] A phase 1 dose escalation study of protein arginine methyltransferase 5 (PRMT5) inhibitor PRT543 in patients with advanced solid tumors and lymphoma
    McKean, Meredith
    Patel, Manish R.
    Wesolowski, Robert
    Ferrarotto, Renata
    Stein, Eytan M.
    Shoushtari, Alexander N.
    Mauro, David
    Viscusi, John
    Scherle, Peggy
    Bhagwat, Neha
    Sun, William
    Chiaverelli, Rachel
    Mintah, Eric
    Jauhari, Shekeab
    Finn, Laura
    Palmisiano, Neil D.
    Baiocchi, Robert A.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [32] PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation
    Jee Won Hwang
    Su-Nam Kim
    Nayeon Myung
    Doona Song
    Gyoonhee Han
    Gyu-Un Bae
    Mark T. Bedford
    Yong Kee Kim
    Communications Biology, 3
  • [33] PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation
    Hwang, Jee Won
    Kim, Su-Nam
    Myung, Nayeon
    Song, Doona
    Han, Gyoonhee
    Bae, Gyu-Un
    Bedford, Mark T.
    Kim, Yong Kee
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [34] METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors
    Postel-Vinay, S.
    Italiano, A.
    Romano, P. Martin
    Cassier, P. A.
    Siu, L. L.
    Lossos, I. S.
    Hilton, J. F.
    Mckean, M. A.
    Strauss, J.
    Falchook, G. S.
    de Jonge, M. J. A.
    Opdam, F. L.
    Rasco, D.
    Vermaat, J. S.
    Crossman, T.
    Zajac, M.
    Hainline, A.
    Kremer, B.
    Barbash, O.
    Gounder, M. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S746 - S747
  • [35] METEOR-1: A phase I study GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours
    Siu, L. L.
    Rasco, D. W.
    Vinay, S. Postel
    Romano, P. Martin
    Menis, J.
    Opdam, F. L.
    Heinhuis, K. M.
    Egger, J. L.
    Gorman, S. A.
    Parasrampuria, R.
    Wang, K.
    Kremer, B. E.
    Gounder, M. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 159 - 159
  • [36] Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3
    Shailesh, Harshita
    Siveen, Kodappully S.
    Sif, Said
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1583 - 1600
  • [37] Tumor Necrosis Factor (TNF)-α Induction of CXCL10 in Endothelial Cells Requires Protein Arginine Methyltransferase 5 (PRMT5)-mediated Nuclear Factor (NF)-κB p65 Methylation
    Harris, Daniel P.
    Bandyopadhyay, Smarajit
    Maxwell, Tyler J.
    Willard, Belinda
    DiCorleto, Paul E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (22) : 15328 - 15339
  • [38] Poly-GR Impairs PRMT1-Mediated Arginine Methylation of Disease-Linked RNA-Binding Proteins by Acting as a Substrate Sink
    Hutten, Saskia
    Chen, Jia-Xuan
    Isaacs, Adrian M.
    Dormann, Dorothee
    BIOCHEMISTRY, 2024, 63 (17) : 2141 - 2152
  • [39] Arginine Methyltransferase 5 (PRMT5) Inhibitors with 3-(1H-benzo[d]imidazol-2-yl)anilines Core Identified by Virtual Screening and Biological Evaluation
    Zhang, Ying
    Zhu, Kongkai
    Zhang, Juan
    Zhang, Jin-He
    Song, Zhiling
    Zhang, Xinlei
    Liu, Shan-Kui
    Jiang, Cheng-Shi
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (06) : 474 - 479
  • [40] Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma
    Sheng, Yan
    Wang, Hongtao
    Liu, Dongchen
    Zhang, Cheng
    Deng, Yupeng
    Yang, Fan
    Zhang, Tingguo
    Zhang, Cuijuan
    GYNECOLOGIC ONCOLOGY, 2016, 140 (01) : 145 - 151